Biotricity (OTCMKTS:BTCY) Shares Up 0.2% – Time to Buy?

Biotricity Inc. (OTCMKTS:BTCY)’s stock price traded up 0.2% on Tuesday . The company traded as high as $0.2419 and last traded at $0.2355. 913 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 35,054 shares. The stock had previously closed at $0.2350.

Biotricity Price Performance

The company’s fifty day moving average is $0.27 and its 200-day moving average is $0.44. The stock has a market cap of $6.58 million, a PE ratio of -1.44 and a beta of 1.36.

Biotricity (OTCMKTS:BTCY) last posted its quarterly earnings results on Wednesday, February 11th. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.04. The business had revenue of $3.99 million during the quarter. Analysts expect that Biotricity Inc. will post -1.43 EPS for the current year.

About Biotricity

Biotricity (OTCMKTS:BTCY) is a medical device and digital health company specializing in remote cardiovascular monitoring and chronic disease management. The company’s flagship offering, the Bioflux system, integrates a wearable ECG patch with a cloud-based analytics platform to deliver real-time heart rhythm data and diagnostic insights. By combining wireless biosensors, mobile applications, and secure data transmission, Biotricity aims to simplify patient monitoring for healthcare providers and enhance early detection of arrhythmias and other cardiac events.

In addition to its core ambulatory ECG solution, Biotricity provides a suite of digital health products designed for broader chronic care management.